SARS-CoV-2 testing: automation of high-throughput qPCR and COVID-seq

Supported by:

19 November 2020

Supported by:

19 November 2020

SPT Labtech webinar image


We have heard time and time again that expanding COVID-19 testing capacity is integral for ending the current global health crisis. As the demand for testing grew, reagent supplies dwindled for the standard qPCR test. This led to innovation in miniaturising the assay to stretch reagent stores and the emergence of new assays to detect the presence of SARS-CoV-2.

In this on-demand webinar, we explore the various methods of COVID-19 testing: qPCR, COVID-seq, antigen and antibody detection, and others. Coupling these assays with low volume, high speed automation has made great strides toward achieving the high-throughput testing essential to ending this pandemic.

Learning outcomes of this webinar:

  • SPT Labtech instrumentation/technology
  • Major types of SARS-CoV-2 workflows: C19 qPCR and COVID-seq
  • Other methods of testing (antigen, antibody, other combined assays)
  • Lessons learned for setting up a new HTS testing core.


Register to watch this on-demand webinar

    Unless making a secure payment with your credit or debit card via a third-party payment processor, this form is not designed to collect confidential or sensitive personal information (e.g., financial information, social security numbers).

    *Required field

    Your details

    Other information

    Email preferences

    If you’re not already opted-in to receive our emails, please select which types of communication you would like to receive:

    Confirm that you're human

    By clicking register, you consent to Drug Target Review contacting you about this and future webinars, and that you agree to our terms and conditions and privacy policy. Your information will be processed in accordance with GDPR and you can unsubscribe at any time.


    Samantha Lee, Field Applications Scientist, SPT LabtechSamantha Lee

    Samantha Lee is a Field Applications Scientist at SPT Labtech who earned her Bachelors in Biochemistry and master’s in Biotechnology from the University of Nevada, Reno. She went on to work as a Research Associate in the biotechnology industry, focusing on automated high-throughput drug screening before pursuing a PhD in Biochemistry at Purdue University. Samantha’s time at SPT Labtech has enabled her to contribute to a plethora of scientific fields including agrigenomics, structural biology and COVID-19 sequencing.

    Holly Hung, Field Applications Scientist, SPT LabtechHolly Hung

    Holly Hung is a Field Applications Scientist at SPT Labtech who received a bachelors in Biochemistry and then later a PhD in Cellular and Molecular Pathology. Her postdoctoral work characterised cancer patient molecular profiles for better treatment selection at the University of Michigan and now through SPT Labtech has been able to make a difference in COVID-19 testing through facilitating automation of high-throughput viral testing.

    2 responses to “SARS-CoV-2 testing: automation of high-throughput qPCR and COVID-seq”

    1. Aw, this was an exceptionally good post. Taking the time and actual effort to create
      a very good article… but what can I say… I put things off a whole lot and
      never seem to get anything done.

    2. Gemechu Chala Hunderra says:

      how could I get the download option so that i could also be able to watch it outdoors

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    This site uses Akismet to reduce spam. Learn how your comment data is processed.